1
|
Force T and Kerkela R: Cardiotoxicity of
the new cancer therapeutics-mechanisms of, and approaches to, the
problem. Drug Discov Today. 13:778–784. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Tuerk C and Gold L: Systematic evolution
of ligands by exponential enrichment: RNA ligands to bacteriophage
t4 DNA polymerase. Science. 249:505–510. 1990. View Article : Google Scholar : PubMed/NCBI
|
3
|
Shangguan D, Li Y, Tang Z, Cao ZC, Chen
HW, Mallikaratchy P, Sefah K, Yang CJ and Tan W: Aptamers evolved
from live cells as effective molecular probes for cancer study.
Proc Natl Acad Sci USA. 103:11838–11843. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Taghdisi SM, Lavaee P, Ramezani M and
Abnous K: Reversible Targeting and controlled release delivery of
daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Eur J Pharm Biopharm. 77:200–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shigdar S, Macdonald J, O'Connor M, Wang
T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, et al:
Aptamers as theranostic agents: Modifications, serum stability and
functionalisation. Sensors (Basel). 13:13624–13637. 2013.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Fang X and Tan W: Aptamers generated from
cell-SELEX for molecular medicine: A chemical biology approach. Acc
Chem Res. 43:48–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Alibolandi M, Ramezani M, Abnous K and
Hadizadeh F: AS1411 aptamer-decorated biodegradable polyethylene
glycol-poly(lactic-co-glycolic acid) nanopolymersomes for the
targeted delivery of gemcitabine to non-small cell lung cancer in
vitro. J Pharm Sci. 105:1741–1750. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Keefe AD, Pai S and Ellington A: Aptamers
as therapeutics. Nat Rev Drug Discov. 9:537–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sperlich C and Saad F: Optimal management
of patients receiving cabazitaxel-based chemotherapy. Can Urol
Assoc J. 7 (1-2 Suppl 1):S18–S24. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shangguan D, Meng L, Cao ZC, Xiao Z, Fang
X, Li Y, Cardona D, Witek RP, Liu C and Tan W: Identification of
liver cancer-specific aptamers using whole live cells. Anal Chem.
80:721–728. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ishii M, Koyama A, Iseki H, Narumi H,
Yokoyama N and Kojima N: Anti-allergic potential of
oligomannose-coated liposome-entrapped Cry j I as immunotherapy for
Japanese cesar pollinosis in mice. Int Immunopharmacol.
10:1041–1046. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Banghan AD and Horne RW: Negative staining
of phospholipids and their structural modification by-surface
active agents as observed in electron microscope. J Mol Biol.
8:660–668. 1964. View Article : Google Scholar : PubMed/NCBI
|
13
|
Szoka F Jr and Papahadjopoulos D:
Procedure for preparation of liposomes with large internal aqueous
space and high capture by reverse-phase evaporation. Proc Natl Acad
Sci USA. 75:4194–4198. 1978. View Article : Google Scholar : PubMed/NCBI
|
14
|
He C, Hu Y, Yin L, Tang C and Yin C:
Effects of particle size and surface charge on cellular uptake and
biodistribution of polymeric nanoparticles. Biomaterials.
31:3657–3666. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sethna SM and Shah NM: The chemistry of
coumarins. Chem Rev. 36:1–62. 1945. View Article : Google Scholar
|
16
|
Malhotra M, Dhingra R, Sharma T, Deep A,
Narasimhan B, Phogat P and Sharma PC: Cabazitaxel: A novel drug for
hormone-refractory prostate cancer. Mini Rev Med Chem. 13:915–920.
2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Medarova Z, Pham W, Farrar C, Petkova V
and Moore A: In vivo imaging of siRNA delivery and silencing in
tumors. Nat Med. 13:372–377. 2007. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Chen Z, Tai Z, Gu F, Hu C, Zhu Q and Gao
S: Aptamer-mediated delivery of docetaxel to prostate cancer
through polymeric nanoparticles for enhancement of antitumor
efficacy. Eur J Pharm Biopharm. 107:130–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Brown DM and Todd AR: 13. Nucleotides.
Part X. Some observations on the structure and chemical behaviour
of the nucleic acids. J Chem Soc. 52–58. 1952. View Article : Google Scholar
|
20
|
Beaucage SL and Caruthers MH:
Deoxynucleoside phosphoramidites-A new class of key intermediates
for deoxypolynucleotide synthesis. Tetrahedron Lett. 22:1859–1862.
1981. View Article : Google Scholar
|
21
|
Reese CB: Oligo-and poly-nucleotides: 50
years of chemical synthesis. Org Biomol Chem. 3:3851–3868. 2005.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Peer D, Karp JM, Hong S, Farokhzad OC,
Margalit R and Langer R: Nanocarriers as an emerging platform for
cancer therap. Nat Nanotechnol. 2:751–760. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shrivastava G, Hyodo M, Yoshimura SH,
Akita H and Harashima H: Identification of a
nucleoporin358-specific RNA aptamer for use as a nucleus-targeting
liposomal delivery system. Nucleic Acid Ther. 26:286–298. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Scaggiantie B, Dapas B, Farra R, Grassi M,
Pozzato G, Giansante C, Fiotti N, Tamai E, Tonon F and Grassi G:
Aptamers as targeting delivery devices or anti-cancer drugs for
fighting tumors. Curr Drug Metab. 14:565–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Aravind A, Jeyamohan P, Nair R,
Veeranarayanan S, Nagaoka Y, Yoshida Y, Maekawa T and Kumar DS:
AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor
cell targeting and drug delivery. Biotechnol Bioeng. 109:2920–2931.
2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Li L, Hou J, Liu X, Guo Y, Wu Y, Zhang L
and Yang Z: Nucleolin-targeting liposomes guided by aptamer AS1411
for the delivery of siRNA for the treatment of malignant melanoma.
Biomaterials. 35:3840–3850. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Chu C, Xu P, Zhao H, Chen Q, Chen D, Hu H,
Zhao X and Qiao M: Effect of surface ligand density on cytotoxicity
and pharmacokinetic profile of docetaxel loaded liposomes. Asian J
Pharm Sci. 11:655–661. 2016. View Article : Google Scholar
|
28
|
Batzei S and Korn ED: Interaction of
phospholipid vesicles with cells. Endocytosis and fusion as
alternate mechanisms for the uptake of lipid-soluble and
water-soluble molecules. J Cell Biol. 66:621–634. 1975. View Article : Google Scholar : PubMed/NCBI
|
29
|
Szymanowskia F, Hugoa AA, Alvesc P,
Simõesc PN, Gómez-Zavagliaa A and Péreza PF: Endocytosis and
intracellular traffic of cholesterol-PDMAEMA liposome complexes in
human epithelial-like cells. Colloids Surf B Biointerfaces.
156:38–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Le UM and Cui Z: Biodistribution and
tumor-accumulation of gadolinium (Gd) encapsulated in
long-circulating liposomes in tumor-bearing mice for potential
neutron capture therapy. Int J Pharm. 320:96–103. 2006. View Article : Google Scholar : PubMed/NCBI
|